Cargando…
Immunological profiling as a means to invigorate personalized cancer therapy
Immunotherapy has taken off but has not yet reached its cruising altitude and is certainly far from its final destination. Identifying the unique immunological profile of individual cancer patients will provide critical clues for the design of optimal strategies that rectify tumor-induced immune imb...
Autores principales: | Hegmans, Joost PJJ, Aerts, Joachim GJV |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805634/ https://www.ncbi.nlm.nih.gov/pubmed/24167762 http://dx.doi.org/10.4161/onci.25236 |
Ejemplares similares
-
The immunological profile of tumor-bearing animals determines the outcome of cancer immunotherapy
por: Quetglas, José I, et al.
Publicado: (2013) -
Tumour-derived exosomes as antigen delivery carriers in dendritic cell-based immunotherapy for malignant mesothelioma
por: Mahaweni, Niken M., et al.
Publicado: (2013) -
Immunological targeting of cytomegalovirus for glioblastoma therapy
por: Nair, Smita K, et al.
Publicado: (2014) -
COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function
por: Veltman, Joris D, et al.
Publicado: (2010) -
The pancreatic cancer microenvironment: an immunologic battleground
por: Pillarisetty, Venu G
Publicado: (2014)